| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/11/2001 | CA2378525A1 A solid formulation of glucosamine sulphate |
| 01/11/2001 | CA2378521A1 Pharmaceutical tablets |
| 01/11/2001 | CA2376944A1 A substantially crystalline form of melagatran |
| 01/11/2001 | CA2376291A1 Patch package and packaged patch |
| 01/11/2001 | CA2375748A1 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 01/11/2001 | CA2375157A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | CA2375085A1 Sustained release dosage form unit having latex coating and method of making the same |
| 01/11/2001 | CA2374931A1 Solid preparations containing paroxetine |
| 01/11/2001 | CA2373979A1 Pre-formed gel sheet |
| 01/11/2001 | CA2373735A1 Fviia antagonists |
| 01/10/2001 | EP1066836A1 Filler/binder hollow particles for tablets |
| 01/10/2001 | EP1066833A2 Cryopreserved cells, system for supplying cells on commission, and preventive or remedial method of infections or cancers |
| 01/10/2001 | EP1066829A1 Stable microemulsions for administration of fatty acids, and use thereof |
| 01/10/2001 | EP1066828A1 Medicaments |
| 01/10/2001 | EP1066761A2 Compositions containing fat-soluble substances in a carbohydrate matrix |
| 01/10/2001 | EP1066380A2 Soluble t cell receptor |
| 01/10/2001 | EP1066081A1 Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems |
| 01/10/2001 | EP1066074A1 Aerosolized active agent delivery |
| 01/10/2001 | EP1066059A1 Formulations for protection of peg-interferon alpha conjugates |
| 01/10/2001 | EP1066057A1 Hemoglobin-polysaccharide conjugates |
| 01/10/2001 | EP1066054A2 Use of active p40 conjugates for nasal delivery |
| 01/10/2001 | EP1066049A1 Pharmaceutical compositions for prolonged peptide release and preparation method |
| 01/10/2001 | EP1066046A2 Composition for pharmaceutical use and/or for use as a nutrition supplement, for humans or animals |
| 01/10/2001 | EP1066040A1 Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption |
| 01/10/2001 | EP1066034A1 Oxy-vanadium (iv) complexes having spermicidal activity |
| 01/10/2001 | EP1066032A1 Sachet formulations |
| 01/10/2001 | EP1066031A2 Method for the production of micro capsules |
| 01/10/2001 | EP1066030A1 Topical hormonal composition with systemic effect |
| 01/10/2001 | EP1066029A1 Peroral active agent suspension |
| 01/10/2001 | EP1066028A2 Methods and devices for modulating the immune response |
| 01/10/2001 | EP1066027A1 Pharmaceutical composition of topiramate |
| 01/10/2001 | EP1066013A1 Method for producing gelatin capsules |
| 01/10/2001 | EP1065978A1 Implantable therapeutic device and method |
| 01/10/2001 | EP1065939A1 Calcium-based chewy nougat formulation with magnesium |
| 01/10/2001 | EP1065936A1 Encapsulation of components into edible products |
| 01/10/2001 | EP0949933A4 Use of cyanoacrylate adhesives for providing a protective barrier film for the skin |
| 01/10/2001 | EP0946637B1 Polymer film compositions for capsules |
| 01/10/2001 | EP0896525A4 Methods of dry powder inhalation |
| 01/10/2001 | EP0888379B1 Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof |
| 01/10/2001 | EP0796103B1 Use of incense in the treatment of alzheimer's disease |
| 01/10/2001 | EP0726761B1 Microparticular pharmaceutical compositions in micellar form |
| 01/10/2001 | EP0717989B1 Process for coating droplets or nanometric particles |
| 01/10/2001 | CN1279701A Gelatine compositions |
| 01/10/2001 | CN1279616A Synergistic composition and methods for treating neoplanstic or cancerous growths and for restoring or boosting hematopoiesis |
| 01/10/2001 | CN1279611A Mechod for treating postmenopausal women using ultra-low-doses of estrogen |
| 01/10/2001 | CN1279608A Formulations comprising dissolved paroxetine |
| 01/10/2001 | CN1279607A Anaesthetic formulation |
| 01/10/2001 | CN1279582A Serotonin containing formulation or oral administration and method of use |
| 01/10/2001 | CN1279112A Composition with carbohydrate matrix containing liposoluble substance |
| 01/10/2001 | CN1279110A In-colon release-controlled thymopeptide capsule and process for extracting and separating thymopeptide |
| 01/10/2001 | CN1279102A Health-care Chinese-medicinal inhalation and its preparing process |
| 01/10/2001 | CN1279100A Exterior-applied medicine for treating neck, lumbus and abdomen diseases, its preparing process, and recovery band |
| 01/10/2001 | CN1279098A Nutritive health-care instant partides |
| 01/10/2001 | CN1279095A Oral medicine for treating rheumetism and its preparing process |
| 01/10/2001 | CN1279091A Process for prefaring plaster to treat cervical or lumbor vertebra disease, headache and neuralgia |
| 01/10/2001 | CN1279068A Aqueous solution for parenteral absorption |
| 01/10/2001 | CN1279067A Defervescent picking for baby |
| 01/10/2001 | CN1279066A Shuangmidamo suppository and its preparing process |
| 01/10/2001 | CN1279064A Roptazol suppository and its preparing process |
| 01/10/2001 | CN1279058A Aqueously dispersing fingernail enamel |
| 01/10/2001 | CN1060388C Ointment for treating hyperosclerosis and its preparation method |
| 01/10/2001 | CN1060383C Pills for cancers |
| 01/10/2001 | CN1060370C Medical ointment for treating arthritis and hyperosteogeny |
| 01/10/2001 | CN1060363C Chinese drugs preparation for hyperosclerosis |
| 01/10/2001 | CN1060362C Prepn. process of sanitary embolus |
| 01/10/2001 | CN1060358C Medical ointment for hyperosteogeny |
| 01/10/2001 | CN1060353C Medicine for cough and asthma |
| 01/10/2001 | CN1060351C Nutritive preparation for computer operator and its production technology |
| 01/10/2001 | CN1060350C Chinese medicine for treatment of woman postpartum disease |
| 01/10/2001 | CN1060349C Capsule for regulating menstruation and eliminating chloasma and preparing method |
| 01/10/2001 | CN1060348C Antidiarrheal granular for baby pig and method for preparing same |
| 01/10/2001 | CN1060347C Capsule for eliminating pathogenic factor and alleviating pain |
| 01/10/2001 | CN1060337C Bear bile powder enteric capsule and preparing technology |
| 01/10/2001 | CN1060336C Medicine for prevention and treatment of calcium deficiency and its prepn. |
| 01/10/2001 | CN1060333C Traditional Chinese medicine emplastrum and manufacture method thereof |
| 01/09/2001 | US6173202 Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 01/09/2001 | US6172219 Esterification, lactonization, salt formation; cosmetics, food packaging, drug carriers |
| 01/09/2001 | US6172107 Mycophenolate salt disintegrates selectively in intestines |
| 01/09/2001 | US6172090 Side effect reduction by administering an insulin sensitivity enhancer such as pioglitazone hydrochloride with a biguanide such as metformin |
| 01/09/2001 | US6172089 Pharmaceutical composition |
| 01/09/2001 | US6172059 Controlling particle size |
| 01/09/2001 | US6172049 Supplying macromolecules to cells |
| 01/09/2001 | US6172048 Composition containing nucleic acids, preparation and uses |
| 01/09/2001 | US6171860 Oligonucleotides which target untranslated regions and start codons to prevent transcription of a gene; for treatment of bone disorders, inflammation and cancer; antiinflammatory agents; anticarcinogenic agents; antitumor agents |
| 01/09/2001 | US6171778 Using solution containing arabinogalactan to remove impurities and protect viability |
| 01/09/2001 | US6171619 Spherical granule, process for producing the same, and spherical granule preparations using the same |
| 01/09/2001 | US6171618 Combination dosage form comprising cetirizine and pseudoephedrine |
| 01/09/2001 | US6171617 Effervescent ibuprofen preparation and process for the production thereof |
| 01/09/2001 | US6171616 Solid preparation and a method of manufacturing it |
| 01/09/2001 | US6171615 Semi-solid matrix of polyglycolized glycerides and nucleation enhancer |
| 01/09/2001 | US6171614 Reductive amination; liposomes |
| 01/09/2001 | US6171613 Method for producing liposomes with increased percent of compound encapsulated |
| 01/09/2001 | US6171611 Prevention of sore throats |
| 01/09/2001 | US6171609 Intravascular stent with cytoskeletal inhibitor; preventing stenosis or reducing restenosis |
| 01/09/2001 | US6171606 Flexible therapeutic copper patch and brace |
| 01/09/2001 | US6171600 Cosmetics, drugs |
| 01/09/2001 | US6171599 Process for producing efonidipine hydrochloride preparations |
| 01/09/2001 | US6171294 Method and device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 01/09/2001 | US6170717 Valve for aerosol container |
| 01/09/2001 | CA2234469C Use of an encapsulated bioactive composition |